Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C

##plugins.themes.academic_pro.article.sidebar##

Published Feb 26, 2014
Download
pdf
Vol. 92 No. 1 (2014): Issue Jan 2014

##plugins.themes.academic_pro.article.main##

Rym Ennaifer
Service de Gastro-entérologie Hôpital H. Thameur Tunis
Myriam Cheikh
Hayfa Romdhane
Service de Gastro-entérologie A. Hôpital la Rabta. Tunis
Rania Hefaiedh
Houda Ben Nejma
Najet Bel Hadj

##plugins.themes.academic_pro.article.details##

References

  1. National Institute of Health. National Institute of Health Consensus Development Conference Statement: management of hepatitis C. Hepatology 2002; 36: S3-S20.
  2. Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002; 36: 237-244.
  3. Borgia G, Reynaud L, Gentile I et al. Pernicious anemia during IFN alfa treatment for chronic hepatitis C. J. Interferon Cytokine Res 2003; 23: 11-12.
  4. Mac Murray RW, Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997; 26: 689-690.